Cercador de Publicacions

La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts.

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

PMID: 35822847
Revista: Future cardiology
Any: 2022
Referència: Future Cardiol. 2022 Jul 13. doi: 10.2217/fca-2022-0044.
Factor d'impacte: 0
Tipus de publicació: Revisió en revista internacional
Autors: Barrios, Vivencio, Cinza-Sanjurjo, Sergio, Garcia-Alegria, Javier, Freixa-Pamias, Roman, Llordachs-Marques, Frederic, Molina, Carlos A, Santamaria, Amparo, Suarez Fernandez, Carmen, Vivas, David et al.
DOI: 10.2217/fca-2022-0044

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

PMID: 35822847
Revista: Future cardiology
Any: 2022
Referència: Future Cardiol. 2022 Sep;18(9):743-754. doi: 10.2217/fca-2022-0044. Epub 2022 Jul 13.
Factor d'impacte:
Tipus de publicació: Revisió en revista internacional
Autors: Barrios, Vivencio; Cinza-Sanjurjo, Sergio; Freixa-Pamias, Roman; Garcia-Alegria, Javier; Llordachs-Marques, Frederic; Molina, Carlos A; Santamaria, Amparo; Suarez Fernandez, Carmen; Vivas, David et al.
DOI: 10.2217/fca-2022-0044

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

PMID: 34786958
Revista: AMERICAN JOURNAL OF ROENTGENOLOGY
Any: 2022
Referència: AJR Am J Roentgenol. 2022 Jul;219(1):26-27. doi: 10.2214/AJR.21.27069. Epub 2021 Nov 17.
Factor d'impacte: 3.959
Tipus de publicació: Carta amb FI
Autors: Rovira, Alex, Auger, Cristina et al.
DOI: 10.2214/AJR.21.27069

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

PMID: 34786958
Revista: AMERICAN JOURNAL OF ROENTGENOLOGY
Any: 2022
Referència: AJR Am J Roentgenol. 2022 Jul;219(1):26-27. doi: 10.2214/AJR.21.27069. Epub 2021 Nov 17.
Factor d'impacte:
Tipus de publicació: Carta amb FI
Autors: Auger, Cristina; Rovira, Alex et al.
DOI: 10.2214/AJR.21.27069

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

PMID: 35617047
Revista: JOURNAL OF CLINICAL INVESTIGATION
Any: 2022
Referència: J Clin Invest. 2022 Jul 1;132(13). pii: 145660. doi: 10.1172/JCI145660.
Factor d'impacte: 14.808
Tipus de publicació: Article en revista internacional
Autors: Smeets, H J M, Gorman, Grainne S, Bonnen, Penelope E, Taylor, Robert W, Hirano, Michio, Chinnery, Patrick F, Rodenburg, Richard J, Tanji, Kurenai, Shintaku, Jonathan, Pernice, Wolfgang M et al.
DOI: 10.1172/JCI145660

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

PMID: 35617047
Revista: JOURNAL OF CLINICAL INVESTIGATION
Any: 2022
Referència: J Clin Invest. 2022 Jul 1;132(13). pii: 145660. doi: 10.1172/JCI145660.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Blakely, Emma L; Bonnen, Penelope E; Brown, Zuben P; Chinnery, Patrick F; Donaldson, Alan; Eyaid, Wafaa; Frank, Joachim; Gc, Jeevan B; Gorman, Grainne S; Hellebrekers, Debby Mei et al.
DOI: 10.1172/JCI145660

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

PMID: 35298906
Revista: LANCET ONCOLOGY
Any: 2022
Referència: Lancet Oncol. 2022 Apr;23(4):465-478. doi: 10.1016/S1470-2045(22)00122-X. Epub 2022 Mar 14.
Factor d'impacte: 41.316
Tipus de publicació: Article en revista internacional
Autors: de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni et al.
DOI: 10.1016/S1470-2045(22)00122-X

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

PMID: 35298906
Revista: LANCET ONCOLOGY
Any: 2022
Referència: Lancet Oncol. 2022 Apr;23(4):465-478. doi: 10.1016/S1470-2045(22)00122-X. Epub 2022 Mar 14.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Biela, Luciano; Bondarenko, Igor; Cibula, David; Colombo, Nicoletta; de Melo, Andreia Cristina; Dvorkin, Mikhail; Fedenko, Alexander; Goble, Sandra; Kristeleit, Rebecca; Lin, Kevin K et al.
DOI: 10.1016/S1470-2045(22)00122-X

Rumination syndrome, critical review.

PMID: 34023479
Revista: Gastroenterologia y Hepatologia
Any: 2022
Referència: Gastroenterol Hepatol. 2022 Feb;45(2):155-163. doi: 10.1016/j.gastrohep.2021.03.013. Epub 2021 May 21.
Factor d'impacte: 2.102
Tipus de publicació: Revisió en revista nacional
Autors: Alcala-Gonzalez, L G; Serra, X; Barba, E et al.
DOI: 10.1016/j.gastrohep.2021.03.013

Rumination syndrome, critical review.

PMID: 34023479
Revista: Gastroenterologia y Hepatologia
Any: 2022
Referència: Gastroenterol Hepatol. 2022 Feb;45(2):155-163. doi: 10.1016/j.gastrohep.2021.03.013. Epub 2021 May 21.
Factor d'impacte:
Tipus de publicació: Revisió en revista nacional
Autors: Alcala-Gonzalez, L G; Barba, E; Serra, X et al.
DOI: 10.1016/j.gastrohep.2021.03.013

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

PMID: 35680967
Revista: npj Breast Cancer
Any: 2022
Referència: NPJ Breast Cancer. 2022 Jun 9;8(1):72. doi: 10.1038/s41523-022-00439-5.
Factor d'impacte: 6.923
Tipus de publicació: Article en revista internacional
Autors: Cortes, Javier, Carey, Lisa A, Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Dieras, Veronique, Dalenc, Florence, Diamond, Jennifer R, Fontaine, Christel, Rugo, Hope S et al.
DOI: 10.1038/s41523-022-00439-5

Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

PMID: 36027558
Revista: JOURNAL OF CLINICAL ONCOLOGY
Any: 2022
Referència: J Clin Oncol. 2022 Oct 10;40(29):3365-3376. doi: 10.1200/JCO.22.01002. Epub 2022 Aug 26.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Bardia, Aditya; Ciruelos, Eva; Cortes, Javier; Dalenc, Florence; Delaney, Rosemary; Fu, Olivia; Jhaveri, Komal L; Lin, Lanjia; Loirat, Delphine; Marme, Frederik et al.
DOI: 10.1200/JCO.22.01002

Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain.

PMID: 35904132
Revista: Journal of the Pediatric Infectious Diseases Society
Any: 2022
Referència: J Pediatric Infect Dis Soc. 2022 Oct 25;11(10):471-473. doi: 10.1093/jpids/piac076.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Aguilera-Alonso, David; Carrasco-Colom, Jaume; Epalza, Cristina; Escartin-Paredes, Paula; Fumado, Victoria; Grasa, Carlos; Hermoso-Ibanez, Concepcion; Herrero, Blanca; Leoz, Ines; Moraleda, Cinta et al.
DOI: 10.1093/jpids/piac076

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

PMID: 35064011
Revista: Journal for ImmunoTherapy of Cancer
Any: 2022
Referència: J Immunother Cancer. 2022 Jan;10(1). pii: jitc-2021-003777. doi: 10.1136/jitc-2021-003777.
Factor d'impacte: 13.751
Tipus de publicació: Article en revista internacional
Autors: Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O'Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda et al.
DOI: 10.1136/jitc-2021-003777

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

PMID: 35064011
Revista: Journal for ImmunoTherapy of Cancer
Any: 2022
Referència: J Immunother Cancer. 2022 Jan;10(1). pii: jitc-2021-003777. doi: 10.1136/jitc-2021-003777.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Boni, Valentina; Brown, Jubilee; Duan, Tao; Duska, Linda; Ghamande, Sharad; Ghatage, Prafull; Gilbert, Lucy; Guo, Wei; Han, Xinwei; Im, Ellie et al.
DOI: 10.1136/jitc-2021-003777

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease.

PMID: 36275063
Revista: Frontiers in Pediatrics
Any: 2022
Referència: Front Pediatr. 2022 Oct 6;10:967233. doi: 10.3389/fped.2022.967233. eCollection 2022.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Ariceta, Gema; Cruz, Alejandro; Garcia-Ortega, Patricia; Jimenez-Lozano, Ines; Lopez, Mercedes; Lopez, Mercedes; Polo, Aurora Fernandez et al.
DOI: 10.3389/fped.2022.967233

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

PMID: 35171022
Revista: Microbiology Spectrum
Any: 2022
Referència: Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16.
Factor d'impacte: 7.171
Tipus de publicació: Article en revista internacional
Autors: Monforte, Arnau, Los-Arcos, Ibai, Martin-Gomez, Maria Teresa, Campany-Herrero, David, Sacanell, Judith, Berastegui, Cristina, Marquez-Algaba, Ester, Sempere, Abiu, Nuvials, Xavier, Castells, Lluis et al.
DOI: 10.1128/spectrum.01784-21

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

PMID: 35171022
Revista: Microbiology Spectrum
Any: 2022
Referència: Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Berastegui, Cristina; Bravo, Carles; Campany-Herrero, David; Castells, Lluis; Deu, Maria; Gavalda, Joan; Len, Oscar; Los-Arcos, Ibai; Marquez-Algaba, Ester; Martin-Gomez, Maria Teresa et al.
DOI: 10.1128/spectrum.01784-21

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

PMID: 35203878
Revista: Antibiotics-Basel
Any: 2022
Referència: Antibiotics (Basel). 2022 Feb 19;11(2). pii: antibiotics11020275. doi: 10.3390/antibiotics11020275.
Factor d'impacte: 4.639
Tipus de publicació: Revisió en revista internacional
Autors: Tejada, Sofia, Forero, Carlos G, Gallego, Miguel, Soriano, Joan B, Cardinal-Fernandez, Pablo A, Ehrmann, Stephan, Rello, Jordi, Ramirez-Estrada, Sergio et al.
DOI: 10.3390/antibiotics11020275

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

PMID: 35203878
Revista: Antibiotics-Basel
Any: 2022
Referència: Antibiotics (Basel). 2022 Feb 19;11(2). pii: antibiotics11020275. doi: 10.3390/antibiotics11020275.
Factor d'impacte:
Tipus de publicació: Revisió en revista internacional
Autors: Cardinal-Fernandez, Pablo A; Ehrmann, Stephan; Forero, Carlos G; Gallego, Miguel; Ramirez-Estrada, Sergio; Rello, Jordi; Soriano, Joan B; Tejada, Sofia et al.
DOI: 10.3390/antibiotics11020275

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

PMID: 35716692
Revista: LANCET NEUROLOGY
Any: 2022
Referència: Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5.
Factor d'impacte: 44.182
Tipus de publicació: Article en revista internacional
Autors: Lanteri-Minet, Michel; Pozo-Rosich, Patricia; Ettrup, Anders; Christoffersen, Cecilie Laurberg; Josiassen, Mette Krog; Phul, Ravinder; Sperling, Bjorn; Ashina, Messoud et al.
DOI: 10.1016/S1474-4422(22)00185-5

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

PMID: 35716692
Revista: LANCET NEUROLOGY
Any: 2022
Referència: Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Ashina, Messoud; Christoffersen, Cecilie Laurberg; Ettrup, Anders; Josiassen, Mette Krog; Lanteri-Minet, Michel; Phul, Ravinder; Pozo-Rosich, Patricia; Sperling, Bjorn et al.
DOI: 10.1016/S1474-4422(22)00185-5

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

PMID: 34942136
Revista: LANCET NEUROLOGY
Any: 2022
Referència: Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
Factor d'impacte: 44.182
Tipus de publicació: Article en revista internacional
Autors: Goemans, Nathalie; Mercuri, Eugenio; Deconinck, Nicolas; Mazzone, Elena S; Nascimento, Andres; Oskoui, Maryam; Saito, Kayoko; Vuillerot, Carole; Baranello, Giovanni; Boespflug-Tanguy, Odile et al.
DOI: 10.1016/S1474-4422(21)00367-7

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

PMID: 34942136
Revista: LANCET NEUROLOGY
Any: 2022
Referència: Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Abbati, Francesca; Akiyama, Kiyomu; Alemdaroglu, Ipek; Almeida Pereira, Jaqueline; Amorelli, Giulia Maria; Arnoldi, Maria Teresa; Arpin, Stephanie; Ayse Karaduman, Aynur; Balikova, Irina; Balikova, Irina et al.
DOI: 10.1016/S1474-4422(21)00367-7

Publicacions

Cercador de Publicacions

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

Rumination syndrome, critical review.

Rumination syndrome, critical review.

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain.

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease.

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

Patronat:

Col·labora:

Acreditacions: